Blockage of DCLK1 in cardiomyocytes suppresses myocardial inflammation and alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic mice.
Ji L, Yang X, Jin Y, Li L, Yang B, Zhu W, Xu M, Wang Y, Wu G, Luo W, et al. Biochim Biophys Acta Mol Basis Dis. 2024 Jan; 1870(1):166900. Epub 2023 Sep 29.